Pfizer CEO Bourla ‘Cautiously Optimistic’ About Tariffs, Pricing Policies

2025 Guidance Reaffirmed, Tariff Impacts Not Included

 
• By Mandy Jackson
  
Pharma product tariffs may be lower for US allies and higher for countries that are not, Bourla opined (Shutterstock)

More from Earnings

More from Scrip